Search

Displaying results 7661 - 7670 of 8696 in total
  1. Drug

    Indantadol

    go.drugbank.com/drugs/DB12664
    Investigational

    Indantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  2. Drug

    Tretoquinol

    go.drugbank.com/drugs/DB13692
    Investigational

    Categories: Adrenergics for Systemic Use, Drugs for Obstructive Airway Diseases
  3. Drug

    Insulin-like growth factor II

    go.drugbank.com/drugs/DB14472
    Investigational

    To perform its biological activities, this growth factor can present some dependence to [somatotropin].

  4. Drug

    Emepronium

    go.drugbank.com/drugs/DB13505
    Experimental

    Categories: Drugs for Urinary Frequency and Incontinence, Drugs for Functional Gastrointestinal Disorders
  5. Drug

    Gaboxadol

    go.drugbank.com/drugs/DB06554
    Investigational

    Gaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck, who reported increased deep sleep without the reinforcing

  6. Drug

    Clonazoline

    go.drugbank.com/drugs/DB15881
    Experimental

    Clonazoline is

  7. Drug

    GI-101

    go.drugbank.com/drugs/DB17243
    Investigational

    GI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation 80 ectodomain as an N-terminal moiety and interleukin-2 variant as a C-terminal moiety

  8. Target

    UDP-glucuronosyltransferases (UGTs)

    go.drugbank.com/bio_entities/BE0009758
    EnzymeHumans

    Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist losartan, a drug which can inhibit the effect of angiotensin II (PubMed:18674515). … Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist caderastan, a drug which can inhibit the effect of angiotensin II (PubMed:18674515).

    Synonyms: hUG-BR1, hUG-BR2
  9. Drug

    Zansecimab

    go.drugbank.com/drugs/DB16389
    Investigational

    Zansecimab is under investigation in clinical trial NCT04342897 (A Study of LY3127804 in Participants With COVID-19).

    Categories: Experimental Unapproved Treatments for COVID-19
  10. Drug

    Tryptamine

    go.drugbank.com/drugs/DB08653
    Investigational

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates